Direxion Daily S&P Biotech Bull 3X SharesLABU
LABU
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
17% more call options, than puts
Call options by funds: $87.4M | Put options by funds: $74.5M
0.99% more ownership
Funds ownership: 5.48% [Q3] → 6.47% (+0.99%) [Q4]
0% more capital invested
Capital invested by funds: $51.9M [Q3] → $51.9M (+$16K) [Q4]
14% less funds holding
Funds holding: 43 [Q3] → 37 (-6) [Q4]
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
Research analyst outlook
We haven’t received any recent analyst ratings for LABU.
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Positive
ETF Trends
1 month ago
Rising Number of Flu Cases Could Elevate These ETFs
Cases of the flu have reached elevated levels as of late. This could keep healthcare stocks and ETFs with a healthcare focus on the radar for traders.
Neutral
ETF Trends
2 months ago
Top Performing Leveraged/Inverse ETFs: 01/26/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Neutral
ETF Trends
4 months ago
There Could Be Value in Healthcare Stocks Ahead of 2025
When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in biotech.
Neutral
ETF Trends
4 months ago
Top Performing Leveraged/Inverse ETFs: 12/01/2024
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Positive
ETF Trends
8 months ago
Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.
Neutral
ETF Trends
8 months ago
Can Biotech Heal Itself?
Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.
Positive
ETF Trends
8 months ago
Top Performing Leveraged/Inverse ETFs: 07/28/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Positive
Zacks Investment Research
8 months ago
Best Inverse/Leveraged ETFs of Last Week
Wall Street offered a mixed performance last week.
Positive
Seeking Alpha
8 months ago
Buy LABU: Biotech Sector Benefits From Lower Interest Rates And AI
Seeking Alpha Quant rates LABU as a “HOLD”, but I rate it as a “BUY”. Markets expect the first interest rate cut at the September Fed meeting. LABU has strong momentum and benefits from lower interest rates.
Charts implemented using Lightweight Charts™